Umbilical Cord Blood

Refractory Immune Cytopenia

The diagnosis is definitely immune cytopenia (IRC), including autoimmune hemolytic anemia (AIHA, Hgb <100g / L, acquired pure red aplastic anemia (PRCA, Hgb <100g / L, EVANS syndrome , Hgb <100g / L and / or platelet count <30 × 109 / L, or blood cell reduction secondary to immune diseases (the same as the treatment indications, or neutrophils <0.5 × 109 / L), at least after hormone therapy Patients who are ineffective (did not reach PR after 4 weeks of hormone therapy) or who have not achieved PR after 3-5 mg / kg / d of cyclosporine. These patients would be treated with umbilical cord blood.

Peking Union Medical College Hospital

Umbilical Cord Blood Treatment for Refractory Immune Cytopenia

Umbilical Cord Blood Treatment for Refractory Immune Cytopenia: a Single-arm Prospective Study

twenty six patients with history of bleeding or had an attack of bleeding during one year follow-up. All underwent upper gastrointestinal endoscopy.

thirty four patients without bleeding. All underwent upper gastrointestinal endoscopy.

Portal Hypertension

Upper gastrointestinal endoscopy using the Pentax video endoscope EG 3440

Upper gastrointestinal endoscopy

Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal Hypertension

Sara Abdelhakam

Assistant Professor

Ain Shams University

D1-4 cyclophosphamide 50 mg/kg IV, then cyclosporine starting on d14 at 12 mg/kg/d for 6 months

ATG at 40 mg/kg/d for 4 days then cyclosporine at 12 mg /kg/d for 6 months

hemoglobinuria/kanama

Umbilical Cord Blood Treatment for Refractory Immune Cytopenia

Risk Factors for Variceal Bleeding in Egyptian Patients With Non-Cirrhotic Portal Hypertension

Comparing Therapies for the Treatment of Severe Aplastic Anemia

Bilim tarafından desteklenen en eksiksiz şifalı otlar veritabanı